Back to STATE STREET CORP STATE STREET CORP

ACRSACRS
28 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ACLARIS THERAPEUTICS INC

STATE STREET CORP holds 3.3M shares of ACRS (ACLARIS THERAPEUTICS INC), worth $17.2M as of 2026-Q2. The position was increased (+62.1% shares). ACRS represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$17.2M

Current Shares

3.3M

Total Value Change

+$16.4M

Total Shares Change

+2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.3M
+62.1%
$17.2M0.0%$5.29
41
2026-Q1
Increased
2M
+33.4%
$7.5M0.0%$3.75
35
2025-Q4
Increased
1.5M
+35.3%
$4.5M0.0%$3.01
35
2025-Q3
Increased
1.1M
+10.6%
$2.1M0.0%$1.90
29
2025-Q2
Increased
1M
+147.1%
$1.4M0.0%$1.42
41
2025-Q1
Increased
407,525
+27.6%
$623,5130.0%$1.53
21
2024-Q4
Increased
319,275
+69.2%
$791,8020.0%$2.48
25
2024-Q3
Decreased
188,721
-4.0%
$217,0290.0%$1.15
0
2024-Q2
Decreased
196,621
-85.3%
$216,2830.0%$1.10
0
2024-Q1
Decreased
1.3M
-3.6%
$1.7M0.0%$1.24
0
2023-Q4
Decreased
1.4M
-11.1%
$1.5M0.0%$1.05
0
2023-Q3
Increased
1.6M
+7.6%
$10.7M0.0%$6.85
30
2023-Q2
Increased
1.5M
+2.0%
$15.1M0.0%$10.37
29
2023-Q1
Increased
1.4M
+9.2%
$11.5M0.0%$8.09
30
2022-Q4
Increased
1.3M
+0.0%
$20.5M0.0%$15.75
28
2022-Q3
Increased
1.3M
+5.9%
$20.5M0.0%$15.74
30
2022-Q2
Increased
1.2M
+13.6%
$17.2M0.0%$13.96
32
2022-Q1
Increased
1.1M
+3.4%
$18.7M0.0%$17.24
29
2021-Q4
Decreased
1M
-1.0%
$15.2M0.0%$14.54
0
2021-Q3
Decreased
1.1M
-1.1%
$19M0.0%$18.00
0
2021-Q2
Increased
1.1M
+454.7%
$18.8M0.0%$17.56
46
2021-Q1
Increased
192,942
+147.2%
$4.9M0.0%$25.20
43
2020-Q4
Unchanged
78,040
0.0%
$505,0000.0%$6.47
0
2020-Q3
Unchanged
78,040
0.0%
$201,0000.0%$2.57
0
2020-Q2
Decreased
78,040
-88.3%
$126,0000.0%$1.62
0
2020-Q1
Decreased
667,188
-9.5%
$694,0000.0%$1.04
0
2019-Q4
Decreased
737,398
-0.8%
$1.4M0.0%$1.89
0
2019-Q3
First report
743,330
-
$803,0000.0%$1.08
0

Other major holders of ACRS: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used